Gypenoside A|cas 157752-01-7|DC Chemicals

Cas No.:	157752-01-7
SMILES:	[C@@H]1(O[C@@H]2OC[C@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)C(C)(C)C2CC[C@@]3(C)[C@@]4(C)CC[C@H]([C@]5(O)[C@@H](O)OC(/C=C(/C)\C)C5)[C@]4([H])CC[C@]3([H])[C@@]2(C=O)CC1
Formula:	C₄₆H₇₄O₁₇
M.Wt:	899.069576740265
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

COA

Cat. No.	Product name	Field of application
DCC-003	Vincristine	>98%,Standard References
DCZ-289	songorine	purity >98%,Standard References
DCZ-286	8-GERANOPSORALEN	purity >98%,Standard References
DCZ-290	Isobavachin	purity >98%,Standard References
DCZ-292	TECTOCHRYSIN	purity >98%,Standard References
DCZ-291	isorhapontigenin	purity >98%,Standard References
DCZ-287	Protopine	purity >98%,Standard References
DC8874	7-TACA	Impurity D of Cefoperazone
DCQ-033	fraxin	Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.
DC23085	Dihydrocapsaicin	Dihydrocapsaicin, a potential inducer of autophagy, has cytotoxic activity. It has anti-atherogenic activity, can reduce the susceptibility of low-density lipoprotein (LDL) to oxidation. Dihydrocapsaicin treatment depletes peptidergic nerve fibers of subs